The GPR139 reference agonists 1a and 7c, and tryptophan and phenylalanine share a common binding site
Abstract GPR139 is an orphan G protein-coupled receptor expressed in the brain, in particular in the habenula, hypothalamus and striatum. It has therefore been suggested that GPR139 is a possible target for metabolic disorders and Parkinson’s disease. Several surrogate agonist series have been publi...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2017
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/17e7b959f6554066a99116d9312ac208 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:17e7b959f6554066a99116d9312ac208 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:17e7b959f6554066a99116d9312ac2082021-12-02T15:04:52ZThe GPR139 reference agonists 1a and 7c, and tryptophan and phenylalanine share a common binding site10.1038/s41598-017-01049-z2045-2322https://doaj.org/article/17e7b959f6554066a99116d9312ac2082017-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01049-zhttps://doaj.org/toc/2045-2322Abstract GPR139 is an orphan G protein-coupled receptor expressed in the brain, in particular in the habenula, hypothalamus and striatum. It has therefore been suggested that GPR139 is a possible target for metabolic disorders and Parkinson’s disease. Several surrogate agonist series have been published for GPR139. Two series published by Shi et al. and Dvorak et al. included agonists 1a and 7c respectively, with potencies in the ten-nanomolar range. Furthermore, Isberg et al. and Liu et al. have previously shown that tryptophan (Trp) and phenylalanine (Phe) can activate GPR139 in the hundred-micromolar range. In this study, we produced a mutagenesis-guided model of the GPR139 binding site to form a foundation for future structure-based ligand optimization. Receptor mutants studied in a Ca2+ assay demonstrated that residues F1093×33, H1875×43, W2416×48 and N2717×38, but not E1083×32, are highly important for the activation of GPR139 as predicted by the receptor model. The initial ligand-receptor complex was optimized through free energy perturbation simulations, generating a refined GPR139 model in agreement with experimental data. In summary, the GPR139 reference surrogate agonists 1a and 7c, and the endogenous amino acids l-Trp and l-Phe share a common binding site, as demonstrated by mutagenesis, ligand docking and free energy calculations.Anne Cathrine NøhrWillem JespersMohamed A. ShehataLeonard FloryanVignir IsbergKirsten Bayer AndersenJohan ÅqvistHugo Gutiérrez-de-TeránHans Bräuner-OsborneDavid E. GloriamNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-9 (2017) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Anne Cathrine Nøhr Willem Jespers Mohamed A. Shehata Leonard Floryan Vignir Isberg Kirsten Bayer Andersen Johan Åqvist Hugo Gutiérrez-de-Terán Hans Bräuner-Osborne David E. Gloriam The GPR139 reference agonists 1a and 7c, and tryptophan and phenylalanine share a common binding site |
| description |
Abstract GPR139 is an orphan G protein-coupled receptor expressed in the brain, in particular in the habenula, hypothalamus and striatum. It has therefore been suggested that GPR139 is a possible target for metabolic disorders and Parkinson’s disease. Several surrogate agonist series have been published for GPR139. Two series published by Shi et al. and Dvorak et al. included agonists 1a and 7c respectively, with potencies in the ten-nanomolar range. Furthermore, Isberg et al. and Liu et al. have previously shown that tryptophan (Trp) and phenylalanine (Phe) can activate GPR139 in the hundred-micromolar range. In this study, we produced a mutagenesis-guided model of the GPR139 binding site to form a foundation for future structure-based ligand optimization. Receptor mutants studied in a Ca2+ assay demonstrated that residues F1093×33, H1875×43, W2416×48 and N2717×38, but not E1083×32, are highly important for the activation of GPR139 as predicted by the receptor model. The initial ligand-receptor complex was optimized through free energy perturbation simulations, generating a refined GPR139 model in agreement with experimental data. In summary, the GPR139 reference surrogate agonists 1a and 7c, and the endogenous amino acids l-Trp and l-Phe share a common binding site, as demonstrated by mutagenesis, ligand docking and free energy calculations. |
| format |
article |
| author |
Anne Cathrine Nøhr Willem Jespers Mohamed A. Shehata Leonard Floryan Vignir Isberg Kirsten Bayer Andersen Johan Åqvist Hugo Gutiérrez-de-Terán Hans Bräuner-Osborne David E. Gloriam |
| author_facet |
Anne Cathrine Nøhr Willem Jespers Mohamed A. Shehata Leonard Floryan Vignir Isberg Kirsten Bayer Andersen Johan Åqvist Hugo Gutiérrez-de-Terán Hans Bräuner-Osborne David E. Gloriam |
| author_sort |
Anne Cathrine Nøhr |
| title |
The GPR139 reference agonists 1a and 7c, and tryptophan and phenylalanine share a common binding site |
| title_short |
The GPR139 reference agonists 1a and 7c, and tryptophan and phenylalanine share a common binding site |
| title_full |
The GPR139 reference agonists 1a and 7c, and tryptophan and phenylalanine share a common binding site |
| title_fullStr |
The GPR139 reference agonists 1a and 7c, and tryptophan and phenylalanine share a common binding site |
| title_full_unstemmed |
The GPR139 reference agonists 1a and 7c, and tryptophan and phenylalanine share a common binding site |
| title_sort |
gpr139 reference agonists 1a and 7c, and tryptophan and phenylalanine share a common binding site |
| publisher |
Nature Portfolio |
| publishDate |
2017 |
| url |
https://doaj.org/article/17e7b959f6554066a99116d9312ac208 |
| work_keys_str_mv |
AT annecathrinenøhr thegpr139referenceagonists1aand7candtryptophanandphenylalanineshareacommonbindingsite AT willemjespers thegpr139referenceagonists1aand7candtryptophanandphenylalanineshareacommonbindingsite AT mohamedashehata thegpr139referenceagonists1aand7candtryptophanandphenylalanineshareacommonbindingsite AT leonardfloryan thegpr139referenceagonists1aand7candtryptophanandphenylalanineshareacommonbindingsite AT vignirisberg thegpr139referenceagonists1aand7candtryptophanandphenylalanineshareacommonbindingsite AT kirstenbayerandersen thegpr139referenceagonists1aand7candtryptophanandphenylalanineshareacommonbindingsite AT johanaqvist thegpr139referenceagonists1aand7candtryptophanandphenylalanineshareacommonbindingsite AT hugogutierrezdeteran thegpr139referenceagonists1aand7candtryptophanandphenylalanineshareacommonbindingsite AT hansbraunerosborne thegpr139referenceagonists1aand7candtryptophanandphenylalanineshareacommonbindingsite AT davidegloriam thegpr139referenceagonists1aand7candtryptophanandphenylalanineshareacommonbindingsite AT annecathrinenøhr gpr139referenceagonists1aand7candtryptophanandphenylalanineshareacommonbindingsite AT willemjespers gpr139referenceagonists1aand7candtryptophanandphenylalanineshareacommonbindingsite AT mohamedashehata gpr139referenceagonists1aand7candtryptophanandphenylalanineshareacommonbindingsite AT leonardfloryan gpr139referenceagonists1aand7candtryptophanandphenylalanineshareacommonbindingsite AT vignirisberg gpr139referenceagonists1aand7candtryptophanandphenylalanineshareacommonbindingsite AT kirstenbayerandersen gpr139referenceagonists1aand7candtryptophanandphenylalanineshareacommonbindingsite AT johanaqvist gpr139referenceagonists1aand7candtryptophanandphenylalanineshareacommonbindingsite AT hugogutierrezdeteran gpr139referenceagonists1aand7candtryptophanandphenylalanineshareacommonbindingsite AT hansbraunerosborne gpr139referenceagonists1aand7candtryptophanandphenylalanineshareacommonbindingsite AT davidegloriam gpr139referenceagonists1aand7candtryptophanandphenylalanineshareacommonbindingsite |
| _version_ |
1718389001335865344 |